KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 227 filers reported holding KITE PHARMA INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $170,928,000 | +64.1% | 950,600 | -5.4% | 0.38% | +65.9% |
| Q2 2017 | $104,168,000 | +39.0% | 1,004,800 | +5.2% | 0.23% | +44.0% |
| Q1 2017 | $74,942,000 | +136.2% | 954,800 | +34.9% | 0.16% | +127.1% |
| Q4 2016 | $31,729,000 | -20.6% | 707,600 | -1.1% | 0.07% | -15.7% |
| Q3 2016 | $39,979,000 | – | 715,700 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|